4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-001402
Chief Operating Officer acquired 3,310 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prince Joshua S. Chief Operating Officer | 2024-12-31 | Grant or award | +3,310 | $2.51 | $8,300 | 5,981 | D |
Loading xslF345X05/form4-01132025_100154.xml…